News Center

Home page

Peak Report

News reports

Innovative breakthroughs, shaping new advantages; integration and optimization, striving for a hundred years

Release time:

2020-08-14

Innovation Breakthrough and Shaping New Advantages; Integration and Optimization, Endeavour Centennial Road

-Chairman's Message

Spring Festival is coming, we are about to enter the Year of the Dog in 1898, and our Jianfeng Group will also enter the 60th year since its inception. The past sixty years, is our peak forge ahead in sixty years, the continuous development and growth of sixty years. Especially since the reform and opening up, we have boldly explored, through measures such as alliances with township enterprises, stock issuance, cross-industry development, cooperation with central enterprises, transformation and upgrading, etc., we have blazed a path that everyone has never walked, and we have also written our peak 60 years. The glory of the year. This is not only a history of struggle, but also a history of innovation, but also a glorious history of the continuous progress of peak people.

Innovation Master Xiong Peter (Joseph Alois Schumpeter ) once said: Any technological transformation, process reengineering, management improvement, and process optimization belong to the category of innovation. With the development of science and technology, AI has become a reality from an assumption; the rise of emerging industries such as information technology and e-commerce has changed people's traditional thinking mode and way of life. New changes are taking place in the world every day, and the source of this change is "innovation". The world is not what it used to be, and the peak is not what it used to be. It is precisely because of our persistence in continuous innovation that we have flourished in the past 60 years. Innovation requires passion, courage and wisdom. In the future, we still need to continue to innovate in order to make the peak stand firm, continue to be strong, and move towards higher and farther goals.

Comrades, the convening of the 19th National Congress of the Communist Party of China marks that Chinese society has entered a new era. The development of enterprises is undergoing kinetic energy conversion, from high-speed growth to high-quality development. In today's era, the only constant is "change", "survival of the fittest" is the eternal truth. After these years of development, our cement has made extraordinary achievements in industrial layout, technological innovation, and technological transformation of facilities; our medicine has made gratifying achievements in plate layout and product research and development, but in the face of the new era, we will still face great challenges in the Red Sea market. Sixty years of a Jiazi, in the year of the opening of a Jiazi under the peak, we will use advanced strategies, bold innovations, and self-revolution to forge our century-old road. On the road of future development, we should use the wisdom of peak people and persist in continuous innovation to create new advantages; we should keep up with the pace of the development of cement in the world, strengthen ourselves through continuous learning, use advanced technological concepts, and take high-quality development as the main line to enhance the sustainable competitive advantage of our cement and add vitality to the traditional industry; our pharmaceutical industry, based on raw materials, chemical pharmaceuticals, and traditional Chinese medicine, combined with the evolution of the modern disease spectrum, it will play a greater role in tumor pharmaceuticals, infant medicines, and elderly medicines, and do a good job in the "smile curve" of products developed and sold at both ends. In the new year, we will increase investment in the construction of API bases and international generic drug bases, further integrate and optimize new drug research and development, production and sales, and accelerate the development of existing clinical and preclinical series of innovative drugs. The speed of research and development, with customer value and customer needs as our work goals, continuously improve the level of preparations, continuously accelerate the speed of research and development, and continuously improve the quality of drugs. The requirements for the full coverage of the consistency evaluation of domestic preparations have been clear. Only by making truly high-quality and effective products can we win the future and the market.

On the journey of "creating a century-old peak", we will inherit and carry forward the peak spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top, and bravely climb the peak"; we must "innovation, performance, integrity, Responsibility, tolerance" values to arm our employees. We should take excellent enterprises with excellent performance, leading technology, first-class management, well-known brand and core competitiveness as our ultimate goal; we should enhance the core competence of enterprises with innovative mechanism, optimize the layout, enhance the market competitiveness, and enhance the organizational competitiveness through integration and optimization. In this way, there is hope for our peak, and there is hope for our future. "Hundred years of peak" is not a dream!

"Xiongguan Mandao is really like iron, and now we are striding forward from the beginning". Today, we stand at a new historical starting point with the peak cause. Let's make positive progress and forge ahead with the peak 100-year road!

Chairman of Jianfeng Group Jiang Xiaomeng

February 7, 2018

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页